1135361

Acadia Pharmaceuticals Inc. — FEI 3005617555

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
January 27, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
San Diego, CA (United States)

Additional Details

Sponsor, Contract Research Organization